Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Drug Metabolism Reviews|May 18, 2016
Metabolic disposition and biological significance of simple phenols of dietary origin: hydroxytyrosol and tyrosolJose Rodríguez-Morató, Anna Boronat, Aristotelis Kotronoulas, et al.
Frontiers in Pharmacology|April 8, 2020
Acute Effects of 2C-E in Humans: An Observational StudyEsther Papaseit, Eulalia Olesti, Clara Pérez-Mañá, et al.
Frontiers in Pharmacology|February 18, 2020
Mephedrone and Alcohol Interactions in HumansEsther Papaseit, Clara Pérez-Mañá, Elizabeth B de Sousa Fernandes Perna, et al.
Oncoimmunology|January 3, 2024
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancerHélène Poinot, Eloïse Dupuychaffray, Grégoire Arnoux, et al.
British Journal of Haematology|June 4, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvementCarlos Jimenez-Mira, Natalia Tovar, Núria Martínez-Cibrián, et al.
British Journal of Haematology|October 31, 2023
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphomaNúria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
Hemasphere|September 15, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphomaNúria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple MyelomaAina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta, et al.
Hemasphere|June 8, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphomaNil Albiol, Nuria Martínez-Cibrián, Amanda Isabel Pérez, et al.
The Lancet. Haematology|February 6, 2026
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trialValentín Ortiz-Maldonado, Núria Martínez-Cibrian, Leticia Alserawan, et al.
Pageof 2